Dr. Arshed A. Quyyumi has been involved in clinical translational research in cardiovascular diseases for over 25 years. Dr. Quyyumi received his undergraduate degree in Pharmacology and medical degree from the University of London, England. He completed his residency at Guy's and Royal Free Hospitals in London, and cardiology fellowships at National Heart Hospital, London; Massachusetts General Hospital, Boston; and the National Institutes of Health. After completion of his residency and fellowship, he served in several capacities in the Cardiology Branch of National Heart Lung and Blood Institute, NIH in Bethesda, MD, including Senior Investigator and Director of the Cardiac Catheterization Laboratory. In 2001 he was appointed Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and in 2010 he was named Co-Director of the Emory Clinical Cardiovascular Research Institute (ECCRI). Since 2005, Dr. Quyyumi has been awarded more than $21 million in research funding. He serves on the Editorial Boards of several national journals, is a member on several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections. Dr. Quyyumi has authored more than 360 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences.
Title of Abstract
It is well known that bone marrow derived progenitor and stem cells can be identified and the numbers and activity can be measured in circulating blood. The presentation will focus on the physiology and pathophysiology of hematopoietic and endothelial progenitor cell populations in the human circulation. The effect of aging, demographic features such as sex and race, influences of cardiovascular risk factors, and cardiovascular disease on these cell populations will be reviewed. In addition, the diagnostic and prognostic value of circulating progenitor cell populations in determining long-term outcomes including death and other adverse events will be discussed. Enumeration of circulating progenitor cells is a measure of endogenous regenerative capacity.
Dr. Quyyumi's research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease. Other interests have spanned the fields of personalized medicine and disparities in cardiovascular diseases. During his academic career, Dr. Quyyumi has carried out more than 50 NIH, industry-funded, or investigator-initiated projects, including numerous clinical trials.